Unichem Laboratories Limited (NSE:UNICHEMLAB)

Unichem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,176	1,509	1,838	1,092	774.61
Short-Term Investments	-	-	-	2,260	-
Trading Asset Securities	-	13.39	15.36	376.28	2,364
Cash & Short-Term Investments	1,176	1,523	1,853	3,728	3,139
Cash Growth	-22.74%	-17.83%	-50.30%	18.76%	-51.75%
Accounts Receivable	7,788	6,104	5,886	4,954	2,503
Other Receivables	-	136.88	96.35	135.5	428.35
Receivables	7,789	6,241	5,983	5,090	2,931
Inventory	9,887	7,127	6,288	6,083	5,548
Prepaid Expenses	-	206.61	234.32	210.48	189.98
Other Current Assets	133.1	1,878	1,561	1,372	1,965
Total Current Assets	18,986	16,975	15,919	16,484	13,773
Property, Plant & Equipment	13,100	13,171	14,026	14,823	14,464
Long-Term Investments	0.2	0.2	1.61	2.85	1,556
Goodwill	15.5	15.45	15.45	15.45	15.45
Other Intangible Assets	187	-	-	-	-
Long-Term Deferred Tax Assets	257.8	67.75	101.13	43.55	139.54
Other Long-Term Assets	3,147	1,462	1,867	1,818	1,309
Total Assets	35,694	31,693	31,930	33,188	31,257
Accounts Payable	4,026	2,994	2,907	1,832	2,101
Accrued Expenses	-	2,047	699.37	555.94	523.02
Short-Term Debt	3,692	1,553	2,081	2,157	1,006
Current Portion of Long-Term Debt	-	256.63	256.63	256.63	-
Current Portion of Leases	46.1	42.12	51.6	42.18	41.58
Current Income Taxes Payable	43.4	22.07	4.91	20.95	32.61
Current Unearned Revenue	-	76.93	245.27	269.49	282.88
Other Current Liabilities	2,137	88.07	150.56	387.32	1,070
Total Current Liabilities	9,943	7,079	6,396	5,521	5,058
Long-Term Debt	608.1	382.22	636.49	890.11	-
Long-Term Leases	251.9	241.53	114.93	145.71	143.1
Long-Term Deferred Tax Liabilities	-	-	-	-	137.02
Other Long-Term Liabilities	385	280.49	294.95	317.72	290.11
Total Liabilities	11,188	8,069	7,577	7,004	5,689
Common Stock	140.8	140.81	140.81	140.81	140.81
Additional Paid-In Capital	-	13.3	13.3	13.3	13.3
Retained Earnings	-	23,391	23,975	25,061	25,012
Comprehensive Income & Other	24,365	79.31	223.87	969.19	402.42
Shareholders' Equity	24,506	23,624	24,353	26,184	25,568
Total Liabilities & Equity	35,694	31,693	31,930	33,188	31,257
Total Debt	4,598	2,475	3,140	3,492	1,191
Net Cash (Debt)	-3,421	-952.63	-1,288	236.25	1,948
Net Cash Growth	-	-	-	-87.87%	-56.14%
Net Cash Per Share	-48.44	-13.53	-18.29	3.35	27.67
Filing Date Shares Outstanding	70.44	70.41	70.41	70.41	70.41
Total Common Shares Outstanding	70.44	70.41	70.41	70.41	70.41
Working Capital	9,042	9,896	9,523	10,963	8,716
Book Value Per Share	347.90	335.54	345.90	371.90	363.16
Tangible Book Value	24,303	23,609	24,338	26,169	25,553
Tangible Book Value Per Share	345.03	335.32	345.68	371.68	362.94
Land	-	37.8	37.8	37.8	37.8
Buildings	-	5,108	5,101	3,872	3,417
Machinery	-	11,904	11,587	9,123	7,842
Construction In Progress	-	1,227	1,475	4,938	5,675

Source: S&P Global Market Intelligence. Standard template. Financial Sources.